MedPath
HSA Approval

BRIMOCHEK EYE DROPS 0.2%

SIN15099P

BRIMOCHEK EYE DROPS 0.2%

BRIMOCHEK EYE DROPS 0.2%

October 14, 2016

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION, STERILE

OPHTHALMIC

Medical Information

S01EA05

brimonidine

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

Indoco Remedies Limited (Plant II)

Active Ingredients

Brimonidine 1.3mg/ml eqv brimonidine tartrate

2.0mg/ml

Brimonidine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BRIMOCHEK EYE DROPS 0.2% - HSA Approval | MedPath